A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors

Bioorganic & Medicinal Chemistry Letters
1999.0

Abstract

By inserting an oxygen link between the 3-fluorophenyl and the lactone ring of 5,5-dimethyl-3-(3fluorophenyl)-4-(4-methanesulfonylphenyl)-2 (5H)-furanone 1 (DFU), analogs with enhanced in vitro COX-2 inhibitory potency as well as in vivo potency in models of inflammation were obtained.

Knowledge Graph

Similar Paper

A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 1999.0
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile
Bioorganic & Medicinal Chemistry Letters 2002.0
2,2-Dimethyl-4,5-diaryl-3(2 H )furanone derivatives as selective cyclo-oxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2001.0
SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor
Bioorganic & Medicinal Chemistry Letters 1999.0
In Vitro Structure−Activity Relationship and in Vivo Studies for a Novel Class of Cyclooxygenase-2 Inhibitors:  5-Aryl-2,2-dialkyl-4-phenyl-3(2H)furanone Derivatives
Journal of Medicinal Chemistry 2004.0
2,3-Diarylcyclopentenones as Orally Active, Highly Selective Cyclooxygenase-2 Inhibitors
Journal of Medicinal Chemistry 1999.0
Cyclooxygenase-2 Inhibitors. Synthesis and Pharmacological Activities of 5-Methanesulfonamido-1-indanone Derivatives
Journal of Medicinal Chemistry 1995.0
A prodrug approach to COX-2 inhibitors with methylsulfone
Bioorganic & Medicinal Chemistry Letters 2004.0
2-Heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridines as selective and orally active cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 1999.0
Conformationally restricted 3,4-diarylfuranones (2,3a,4,5-tetrahydronaphthofuranones) as selective cyclooxygenase-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2003.0